True North Advisors’s Repligen RGEN Stock Holding History

True North Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,000	Closed	-$741K	–	202
2020 Q2	$741K	Hold	6,000	–	–	0.18%	94
2020 Q1	$579K	Buy	+6,000	New	+$579K	0.2%	65

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

True North Advisors's RGEN Position: Q3 2020 in Review

True North Advisors sold out of Repligen (RGEN) in Q3 2020, closing a stake of 6,000 shares — an estimated $741K sold.

True North Advisors first reported a position in RGEN in Q1 2020 and held it in 2 quarters. The position peaked at $741K in Q2 2020. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.

True North Advisors reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
True North Advisors sold 6,000 Repligen shares in Q3 2020, an estimated $741K.
True North Advisors first reported a position in Repligen in Q1 2020 and held it in 2 quarters.
True North Advisors's Repligen position peaked at $741K in Q2 2020.
390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.

Based on True North Advisors's 13F filing for Q3 2020, filed 20 May 2022.